In an exciting moment for the sector, Nye Health’s innovative platform, which has been instrumental in improving patient engagement and analysis of a variety of data sets, has just been enhanced by integrating IntelliProve’s innovative technology into the platform. Integration of novel technologies is a core part of our strategy and we are always seeking to build new capabilities to generate positive impact for patients.
Nye Health envisions a future where healthcare is data-driven, patient-centered, and accessible.
Nye Health’s Real World Solutions offers a configurable platform designed to enhance Real-World Evidence (RWE) studies, patient-facing registries, early-access management schemes, and any project requiring efficient and high-quality patient data collection. Our platform enables you to swiftly and securely uncover unmet patient needs, driving impactful pathway shaping opportunities.
Nye Health’s Digital Patient Support offer is a cloud-hosted platform designed to revolutionise patient care by providing tailored services that boost engagement and adherence, leading to improved health outcomes. It leverages data analytics to demonstrate real-world value for both patients and the healthcare system, uncovering insights that might otherwise be missed.
IntelliProve's technology perfectly complements Nye Health’s vision by facilitating the creation of more real-world evidence, enhanced patient engagement and empowering patients to actively participate in their health journey. IntelliProve's focus on data-driven insights and user engagement aligns directly with our goals of improving patient outcomes and fostering a more informed and empowered patient population.
There are still challenges in the ways in which we can assess health, many methods are outdated, fraught with possible error and not engaging or easy for the patient. The integration of IntelliProve’s facial analysis technology addresses many of these challenges alongside Nye Health’s intuitive and patient friendly user experience and dashboards.
IntelliProve uses photoplethysmography (PPG) via a patient’s camera on their phone or computer to measure cardiac synchronous blood volume changes in the face.
Within 20 seconds the user can start to view their data dashboard. The output provides clinically validated biomarkers that offer a comprehensive view of the patient’s current health. Biomarkers are measurable indicators of biological processes within your body. Biomarkers that are recorded on IntelliProve include heart rate, heart rate variability, respiratory rate, resonant breathing score, ANS balance, morning readiness score, acute mental stress score and mental health risk.
IntelliProve's technology is backed by more than 10 years of peer-reviewed academic and clinical research. More than one million datapoints are actively being used for testing and validating IntelliProve models.
Brecht Dhuyvetters, Co-founder & CTO of IntelliProve shared his thoughts today; ‘We are excited to partner with Nye Health, it has been a pleasure working with their team during the on-boarding and integration process. It is great to see the consistent enthusiasm from the Nye Health team about the potential of the technology we’ve created for the Health and Wellbeing sector in the UK. What an exciting time to be on the front line of digital innovation in healthcare! We are proud to partner with Nye Health and work together to improve patient outcomes.’
IntelliProve adds significant value to NyeHealth by empowering users to take charge of their health and well-being. This translates into numerous advantages for our platform and our users:
Enhanced User Engagement: IntelliProve's interactive features and personalised insights encourage users to actively participate in their health management, leading to increased engagement with the Nye Health platform and a deeper understanding of their health.
Empowering Users for Informed Decision-Making: The Nye Health platform with IntelliProve integration equips users with the knowledge and tools to make informed decisions about their health, fostering a sense of empowerment and ownership over their well-being.
Strengthening the Patient-Provider Relationship: The ability for patients to share health dashboards and insights with healthcare providers via the Nye Health platform on their device. Utilising data from IntelliProve facilitates more meaningful and productive conversations, leading to personalised treatment plans and improved patient-provider collaboration.
Improved Patient Outcomes: By enabling users to monitor their health data, track symptoms, and adhere to treatment plans, Nye Health and IntelliProve facilitate early detection of potential issues and timely interventions, ultimately leading to better health outcomes.
Dr.Jade Marsh, Product Manager at Nye Health said ‘IntelliProve not only enriches the NyeHealth platform with valuable data and insights but also empowers users to become active participants in their health journey. This creates a virtuous cycle of engagement, empowerment, and improved health outcomes, ultimately fulfilling Nye Health's mission to provide accessible and effective healthcare solutions’.
Book in a meeting with our team to find out more about this latest collaboration and participate in a facial analysis demonstration to understand the potential of this technology for you, your loved ones and your business. We look forward to hearing from you soon: hello@nye.health
Comments